Please Wait...

Cardiac Safety

World-renowned scientific expertise, regulatory leadership and integrated technology for high quality centralized cardiac safety trials.

Cardiovascular Safety Services from Bioclinica

With over 25 years of experience in Cardiac Safety monitoring services, Bioclinica is a recognized global leader in providing comprehensive services with unrivalled scientific and technical leadership. Bioclinica's medical and scientific team, consisting of board-certified cardiologists and active members of the Cardiac Safety Research Consortium, has strong experience in successfully designing and supporting studies that require cardiac safety monitoring. Our focus goes beyond the single study and across the entire cardiac safety profile of the study compound from Phase I–IV. With experience working alongside the ICH, FDA, EMA, PMDA, and SFDA in the development of regulatory and industry guidelines, Bioclinica is the smart choice to support the design and conduct of cardiac safety studies around the globe.

ECG MEASUREMENTS

Manual and automated ECG analysis and Digital Holter analysis.
LEARN MORE

THOROUGH QT STUDIES

Innovative and conventional TQT study design and support.
LEARN MORE

BLOOD PRESSURE

Ambulatory and Automated Blood Pressure and Pulse Wave Analysis.
LEARN MORE

CARDIOVASCULAR IMAGING

Cardiac safety endpoints using a range of imaging modalities.
LEARN MORE

PROTOCOL DESIGN AND EXPERT REPORTING

Study design and Consultative Services.
LEARN MORE

WEBHEART PLATFORM

Robust, validated trial management tool.
LEARN MORE

SCIENTIFIC & REGULATORY EXPERTISE

30+ years of proven strategic expertise.
LEARN MORE

COLLATERAL

Learn more & eBrochures.
LEARN MORE

 

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @MdFacep: FDA approvals: Merck's Keytruda wins FDA approval as combination therapy for kidney cancer. BIG! https://t.co/LgCzL1mvaF @Reu…
Bioclinica (8 hours ago)
RT @FDA_Drug_Info: National Prescription Drug Take Back Day is April 27, 2019 from 10:00 AM to 2:00 PM. Learn how to dispose of unused and…
Bioclinica (8 hours ago)
RT @iofbonehealth: #Osteoporosis Int: Spanish National Hip Fracture Registry (RNFC): analysis of its first annual report and international…
Bioclinica (8 hours ago)
RT @HINJ_ORG: New Jersey's biopharmaceutical industry: CIANJ has assembled a panel of industry leaders @Celgene, @Bayer & @PhRMA to discuss…
Bioclinica (8 hours ago)
RT @PhRMA: Last year, the top 15 largest biopharmaceutical companies spent more than $100 billion on R&D, according to @IQVIA_global. More…
Bioclinica (8 hours ago)
RT @SCDM_DataDriven: Registrations for the SCDM 2019 Annual Conference are now open!! #SCDM2019 Register now for the biggest event in the…
Bioclinica (8 hours ago)

Latest Blogs:

Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box